CTCs serve as clinical tool to determine patient’s response to chemotherapy

[News]

Scientists from Granada have demonstrated, for the first time, that detecting circulating tumour cells (CTCs) in blood and studying the presence of certain genetic markers in them is a technique that allows specialists to predict, with great precision, the response that advanced-cancer patients will have to chemotherapy, as well as the associated secondary effects they may suffer.

More... (http://www.news-medical.net/news/20131204/CTCs-serve-as-clinical-tool-to-determine-patiente28099s-response-to-chemotherapy.aspx)